Company

Mediar Therapeutics

https://www.mediartx.com/

Industryclinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis

Funding raised

CompanyRoundDate
Mediar TherapeuticsSeries B2026-01-07
Mediar TherapeuticsFunding2023-03-15